Skip to main content

BC Partners acquires Havea for $1.16 bln

By: Get News

London-based private equity firm BC Partners has acquired French natural healthcare group Havea from 3i Group (III.L), opens new tab for 1-1.1 billion euros ($1.05 - $1.16 billion), a source familiar with the matter told Reuters.

BC Partners led the investor group in partnership with PSP Investments and National Pensions Services Investment Management (NPS). The bidder intends to accelerate Havea's pace of M&A and continue investing in digitalisation.

"The business has made five key strategic acquisitions since 2017, and we look forward to working with the team to drive Havea's continued international expansion," said Fouad Jaïdi, managing director at BC Partners.

Proceeds to 3i will represent around 50% uplift to its 31 March valuation. Havea, which owns brands such as Aragan, Biolane and Vitavea, employs over 800 people and is headquartered in Boufféré, France.

BC Partnersde senior investment adviser Vikram Chatterjee said: In the future, the company is accelerating the expansion of nationalization and will invest in more markets around the world, such as emerging potential markets such as China, India and Africa.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: ILSC
Contact Person: Media Relations
Email: Send Email
City: NY
Country: United States

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.